US Stem Cell (USRM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,145 | -576 | -3,835 | -3,158 | -1,512 |
| Depreciation Amortization | 165 | 75 | 441 | 296 | 198 |
| Accounts receivable | 26 | 13 | -76 | -33 | -14 |
| Accounts payable and accrued liabilities | 53 | 23 | 345 | 269 | 196 |
| Other Working Capital | 86 | 41 | 97 | 166 | 28 |
| Other Operating Activity | 653 | 329 | 1,818 | 1,469 | 568 |
| Operating Cash Flow | $-162 | $-95 | $-1,211 | $-991 | $-536 |
| Cash Flows From Investing Activities | |||||
| Sale Of Investment | N/A | N/A | 167 | 167 | 167 |
| Investing Cash Flow | $N/A | $N/A | $167 | $167 | $167 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 339 | 137 | 471 | 140 | 90 |
| Common Stock Issued | N/A | N/A | 50 | N/A | N/A |
| Other Financing Activity | -24 | -12 | -834 | -595 | -491 |
| Financing Cash Flow | $315 | $125 | $-313 | $-455 | $-401 |
| Beginning Cash Position | N/A | 0 | 1,357 | 1,357 | 1,357 |
| End Cash Position | 153 | 31 | N/A | 78 | 588 |
| Net Cash Flow | $153 | $31 | $-1,357 | $-1,279 | $-770 |
| Free Cash Flow | |||||
| Operating Cash Flow | -162 | -95 | -1,211 | -991 | -536 |
| Free Cash Flow | -162 | -95 | -1,211 | -991 | -536 |